-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Diabetes mellitus (DM) is a common health problem
in developing countries.
Lower urinary tract symptoms (LUTS) are widespread symptoms that are common in people with diabetes but have a relatively insidious
onset.
DM is known to affect the urinary tract through a variety of mechanisms, such as recurrent urinary tract infections, urinary tract stones, and bladder dysfunction
.
Importantly, LUTS are known to cause physical and psychological distress
.
Therefore, any measures to improve LUTS symptoms in people with diabetes are crucial
.
However, it is unclear
whether strict control of DM directly contributes to LUTS.
Studies have found that regular exercise, weight loss, and fluid adjustment can improve LUTS, but there is no particular effect
in people with diabetes.
Therefore, a detailed analysis of LUTS in diabetic patients is needed to identify modifiable risk factors that may lead to LUTS and thus prevent minor but significant complications
.
This study describes LUTS in people with diabetes, investigates factors that may be associated with it, and evaluates the possible relationship
between LUTS and quality of life in people with diabetes.
We included 378 participants
.
Among them, 29.
9% were in the age range of 58-67 years, and 49% were women
.
Half of the cohort was overweight and one-third obese
.
Most participants had T2DM with a median duration of 14 years
.
Of all participants, only 3.
7% were undergoing lifestyle changes, 56.
6% were receiving monotherapy, and the remainder (39.
7%) were using combination therapy
.
In addition, with the exception of diabetes, most participants had different comorbidities at 65.
3%.
The researchers collected data
using the Urogenital Distress Scale-6 (UDI-6) and the Urinary Incontinence Effects Questionnaire-7 (IIQ-7).
The median score is 5.
50 (2.
00–8.
00) on the UDI-6 scale and 5 (0.
00–10.
00)
on the IIQ-7 scale.
Tables 2 and 3 show the distribution
of responses to each question on the Genitourinary Symptoms Scale for Diabetics.
For example, 49.
7% of the study population mentioned that their urinary symptoms affected their ability to
do household chores.
In addition, 51.
3 per cent, 48.
1 per cent and 50 per cent were restricted
in terms of recreation, recreation and social activities, respectively.
The scale also showed that 55.
4 percent of participants reduced their ability to
travel more than 30 minutes by car or bus.
Regarding the impact on emotional health, 54.
2 percent mentioned some kind of stress and depression related to their condition, and 52.
1 percent described feeling
depressed about their symptoms.
Multiple linear regression models showed that residence (p=0.
038) and regular exercise (p=0.
001) were significantly negatively correlated with UDI-6 scores, while females (p=0.
042), insulin use (p=0.
009), and presence of comorbidities (p=0.
007) were positively correlated
with this score.
In addition, age (p=0.
040) and body mass index (BMI) (p<0.
001) were significantly positively correlated
with IIQ-7 score.
LUTS occurs in
patients with DM.
Some factors, such as age, BMI, and comorbidities, exacerbate LUTS, which can be improved and controlled
.
Therefore, screening questionnaires should be offered primarily to women with diabetes to understand the severity of LUTS and its impact
on quality of life.
On the other hand, regular exercise and weight loss strategies can help diabetics improve LUTS
.
Original source:
Qasrawi H, Tabouni M, Almansour SW, Ghannam M, Abdalhaq A, Abushamma F, Koni AA, Zyoud SH.
An evaluation of lower urinary tract symptoms in diabetic patients: a cross-sectional study.
BMC Urol.
2022 Nov 10; 22(1):178.
doi: 10.
1186/s12894-022-01133-1.
PMID: 36357918; PMCID: PMC9648430.